IHE icon

iShares US Pharmaceuticals ETF

122 hedge funds and large institutions have $125M invested in iShares US Pharmaceuticals ETF in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

more ownership

Funds ownership:

6% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 31

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $233K

Holders
122
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
$233K
Net Calls
Net Calls Change

Top Buyers

1 +$5.53M
2 +$5.41M
3 +$1.87M
4
Bank of America
Bank of America
North Carolina
+$1.73M
5
Goldman Sachs
Goldman Sachs
New York
+$1.62M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$16M
2
$12.1M
3
$8.73M
4
$8.28M
5
$8.12M
6
$7.21M
7
$5.88M
8
$5.53M
9
$4.87M
10
$3.42M
11
$2.56M
12
$2.55M
13
$1.87M
14
$1.86M
15
$1.74M
16
$1.69M
17
$1.63M
18
$1.62M
19
$1.38M
20
$1.24M
21
$1.23M
22
$1.17M
23
$1.16M
24
$1.04M
25
$968K